Minerva Neurosciences (NERV) Other Non-Current Liabilities (2013 - 2026)

Minerva Neurosciences (NERV) has 11 years of Other Non-Current Liabilities data on file, last reported at $60.0 million in Q1 2026.

• For the quarter ending Q1 2026, Other Non-Current Liabilities changed 0.0% year-over-year to $60.0 million; the trailing twelve-month figure through Mar 2026 stood at $60.0 million (changed 0.0% YoY), and the FY2025 full-year result was $60.0 million, changed N/A from the prior year.
• Other Non-Current Liabilities for Q1 2026 stood at $60.0 million, roughly flat from $60.0 million in the prior quarter.
• Across five years, Other Non-Current Liabilities topped out at $86.6 million in Q2 2024 and bottomed at $60.0 million in Q3 2024.
• The 5-year median for Other Non-Current Liabilities is $70.9 million (2022), against an average of $70.6 million.
• The widest annual swing landed in 2024, when Other Non-Current Liabilities climbed 11.37%; it then sank 30.7% in 2025.
• A 5-year view of Other Non-Current Liabilities shows it stood at $73.7 million in 2022, then gained by 11.23% to $82.0 million in 2023, then retreated by 26.84% to $60.0 million in 2024, then changed by 0.0% to $60.0 million in 2025, then changed by 0.0% to $60.0 million in 2026.
• The last three Other Non-Current Liabilities figures came in at $60.0 million (Q1 2026), $60.0 million (Q4 2025), and $60.0 million (Q3 2025), per Business Quant data.

Peer Comparison